Mechanism of Pingchuanning in Attenuating Asthma Based on UHPLC‐Q‐Orbitrap HRMS and Network Pharmacology Analysis
Biomedical Chromatography · 2026-12 · 40 (12)
DOI: 10.1002/bmc.70607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 19.10.2026. Verfasst von Yue Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Anhui University of Chinese Medicine, Hefei, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Asthma, Anti-Asthmatic Agents. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui University of Chinese Medicine, Postdoctoral Research Project of the Department of Human Resources and Social Security of Anhui Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
An ultrahigh‐performance liquid chromatography coupled with quadrupole‐Orbitrap high‐resolution mass spectrometry (UHPLC‐Q‐Orbitrap HRMS) method was applied to characterize Pingchuanning (PCN) decoction and its absorbed serum constituents in asthmatic rats. A total of 107 compounds were identified in PCN, of which 36 prototypes were detected in rat serum. Network pharmacology and molecular docking of these absorbed compounds predicted ADORA2A as the core therapeutic target, with 5‐ O ‐methylvisammioside, nobiletin, sec ‐ O ‐glucosylhamaudol, and 9‐oxo‐ODE showing binding affinity. In an ovalbumin‐induced asthmatic rat model, PCN alleviated airway hyperresponsiveness and lung inflammation. Mechanistically, PCN upregulated ADORA2A, elevated cAMP and PKA phosphorylation, and suppressed NLRP3 expression. This UHPLC‐Q‐Orbitrap HRMS‐based serum pharmacochemistry method effectively identified the bioactive components of PCN, and the integrated strategy demonstrates that PCN exerts anti‐asthmatic effects through the ADORA2A/cAMP/PKA/NLRP3 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui University of Chinese Medicine, Hefei, China.
- School of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China.
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
- Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, China.
ORCID-Profile: Yue Zhang, Yiwen Ding, Weidong Chen
Förderung
- Anhui University of Chinese Medicine
- Postdoctoral Research Project of the Department of Human Resources and Social Security of Anhui Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Ding, Y., Chen, W., Bi, Y., Wang, Y., Ye, W., & Fang, X. (2026). Mechanism of Pingchuanning in Attenuating Asthma Based on UHPLC‐Q‐Orbitrap HRMS and Network Pharmacology Analysis. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70607
Vancouver
Zhang Y, Ding Y, Chen W, Bi Y, Wang Y, Ye W, et al. Mechanism of Pingchuanning in Attenuating Asthma Based on UHPLC‐Q‐Orbitrap HRMS and Network Pharmacology Analysis. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70607
BibTeX
@article{Zhang2026,
author = {Zhang, Yue and Ding, Yiwen and Chen, Weidong and Bi, Yuanbo and Wang, Yanyan and Ye, Weidong and Fang, Xiangming},
title = {Mechanism of Pingchuanning in Attenuating Asthma Based on UHPLC‐Q‐Orbitrap HRMS and Network Pharmacology Analysis},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {12},
doi = {10.1002/bmc.70607}
}
EUVIMED